Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Ponzone

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Advances in Biological Regulation|October 28, 2025
The interplay between phosphoinositides and ESCRT proteinsChiara Giannini, Luca Ponzone, Nicola Barroero, et al.
Cells|April 12, 2022
ROCK 'n TOR: An Outlook on Keratinocyte Stem Cell Expansion in Regenerative Medicine via Protein Kinase InhibitionGiorgia Centonze, Sara Centonze, Luca Ponzone, et al.
International Journal of Molecular Sciences|September 9, 2022
NAD/NAMPT and mTOR Pathways in Melanoma: Drivers of Drug Resistance and Prospective Therapeutic TargetsAlice Indini, Irene Fiorilla, Luca Ponzone, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 28, 2023
Cystine/glutamate antiporter xCT deficiency reduces metastasis without impairing immune system function in breast cancer mouse modelsRoberto Ruiu, Chiara Cossu, Antonella Iacoviello, et al.
Journal of Cell Science|October 27, 2019
Two conserved glycine residues in mammalian and <i>Dictyostelium</i> Rictor are required for mTORC2 activity and integrityBarbara Pergolizzi, Cristina Panuzzo, M Shahzad Ali, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 14, 2026
Bi-directional regulation between NAD/NAMPT and IFN-γ/PD-L1 axes via BRD4/IRF1 and mitochondrial respiration in metastatic cutaneous melanomaIrene Fiorilla, Beatrice Ghezzi, Alessia Ponzano, et al.
Molecular Cancer|May 16, 2024
RICTOR/mTORC2 downregulation in BRAF<sup>V600E</sup> melanoma cells promotes resistance to BRAF/MEK inhibitionLuca Ponzone, Valentina Audrito, Claudia Landi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Advances in Biological Regulation|October 28, 2025
The interplay between phosphoinositides and ESCRT proteinsChiara Giannini, Luca Ponzone, Nicola Barroero, et al.
Cells|April 12, 2022
ROCK 'n TOR: An Outlook on Keratinocyte Stem Cell Expansion in Regenerative Medicine via Protein Kinase InhibitionGiorgia Centonze, Sara Centonze, Luca Ponzone, et al.
International Journal of Molecular Sciences|September 9, 2022
NAD/NAMPT and mTOR Pathways in Melanoma: Drivers of Drug Resistance and Prospective Therapeutic TargetsAlice Indini, Irene Fiorilla, Luca Ponzone, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 28, 2023
Cystine/glutamate antiporter xCT deficiency reduces metastasis without impairing immune system function in breast cancer mouse modelsRoberto Ruiu, Chiara Cossu, Antonella Iacoviello, et al.
Journal of Cell Science|October 27, 2019
Two conserved glycine residues in mammalian and <i>Dictyostelium</i> Rictor are required for mTORC2 activity and integrityBarbara Pergolizzi, Cristina Panuzzo, M Shahzad Ali, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 14, 2026
Bi-directional regulation between NAD/NAMPT and IFN-γ/PD-L1 axes via BRD4/IRF1 and mitochondrial respiration in metastatic cutaneous melanomaIrene Fiorilla, Beatrice Ghezzi, Alessia Ponzano, et al.
Molecular Cancer|May 16, 2024
RICTOR/mTORC2 downregulation in BRAF<sup>V600E</sup> melanoma cells promotes resistance to BRAF/MEK inhibitionLuca Ponzone, Valentina Audrito, Claudia Landi, et al.
Pageof 1